Category 1 status only means a substance is eligible for use by 503A compounding pharmacies pending final FDA rulemaking
Cytoprotective and Anti-Ulcer Activity As a cytoprotective mediator, BPC-157 demonstrates protective effects on the gastrointestinal mucosal barrier while simultaneously addressing lesions in the liver, brain, and cardiovascular tissue
And that is where you can step in and help them
Many clients schedule injections weekly or monthly, depending on their health goals and lifestyle
Whether youre curious about a treatment, booking your first consultation, or continuing your care, our team is here to guide and support you every step of the way.
Individuals most likely to benefit include: Those with pernicious anemia People with gastrointestinal disorders (e.g., Crohns disease, celiac disease, chronic gastritis) Patients following bariatric (weight loss) surgery Older adults with absorption difficulties Strict vegetarians or vegans at risk for deficiency People taking medications that can decrease vitamin B12 levels Laboratory testing usually confirms B12 deficiency before starting injections
